Extended Phenytoin Sodium recalls
Extended Phenytoin Sodium products have been recalled 3 times, most recently on 15 Nov 2023. The recalling company is usually Amneal Pharmaceuticals of New York. The most common reason is potency & assay.
Total recalls3since 2013
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Nov 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why extended phenytoin sodium is recalled
Companies
Product types
By year
All extended phenytoin sodium recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Extended Phenytoin Sodium Capsules, USP, 100 mg recalledExtended Phenytoin Sodium | Amneal Pharmaceuticals of New York | Potency & Assay | Nationwide |
| Drug | CLASS II | Extended Phenytoin Sodium Capsules, USP, 100 mg recalledExtended Phenytoin Sodium | Amneal Pharmaceuticals of New York | Potency & Assay | LA, OH, PA |
| Drug | CLASS II | Extended Phenytoin Sodium Capsules, USP, 100 mg recalledExtended Phenytoin Sodium | Amneal Pharmaceuticals of New York | Potency & Assay | 7 states |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.